Assessing a New Tool to Assess Frailty in Frail Hospitalized Elderly
ConditionFrail Elderly Syndrome
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age65+
SponsorUniversity of British Columbia
About this trial
The major purpose of this study is to establish the use of daily step counts as inexpensive, easy to measure marker for frailty and sarcopenia in an inpatient population of older adults.
Eligibility criteria
Qualifiers
be 65 years of age or older
be admitted in ACE Unit
Disqualifiers
be less than 65 years of age
be nonambulatory
be diagnosed with end-stage organ failure (end-stage COPD, renal failure requiring dialysis, end-stage heart failure)
Trial design
Treatments tested in this trial
- ActivPAL3 VT (PAL Technologies Ltd).
Treatment groups
120 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov